# PD1 Integrated Anti-PSMA CART in Treating Patients With Castrate-Resistant Prostate Cancer

> **NCT04768608** · PHASE1 · COMPLETED · sponsor: **Zhejiang University** · enrollment: 3 (actual)

## Conditions studied

- Castrate-Resistant Prostate Cancer

## Interventions

- **DRUG:** PD1-PSMA-CART cells

## Key facts

- **NCT ID:** NCT04768608
- **Lead sponsor:** Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-23
- **Primary completion:** 2022-06-30
- **Final completion:** 2023-05-30
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2023-07-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04768608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04768608, "PD1 Integrated Anti-PSMA CART in Treating Patients With Castrate-Resistant Prostate Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04768608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*